Please Wait.....
Report
Middle East & Africa Genotyping Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product and Services (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology [Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others], Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Others)
Market Report I 2022-09-16 I 159 Pages I The Insight Partners
The genotyping market in Middle East & Africa is expected to grow from US$ 1,141.17 million in 2022 to US$ 3,176.29 million by 2028. It is estimated to grow at a CAGR of 18.6% from 2022 to 2028.
Genotyping compares a DNA sequence to another sample or a reference sequence to discover variations in genetic complement. It detects single-nucleotide polymorphisms (SNPs), which are minor differences in genetic sequence within the population. The human genome has about 660 million SNPs, making them the most prevalent kind of genetic variation. They can explain features such as eye color and hereditary disorders such as cystic fibrosis and sickle cell anemia and serve as indicators for developing complicated diseases such as cancer, diabetes, and Alzheimer's.
According to the International Diabetes Federation (IDF) Consortium 2019, type 2 diabetes (T2D) is one of the leading causes of death worldwide, accounting for 4.2 million deaths in 2019. According to the same research, Iran ranks third among 20 countries in the Middle East and North Africa (MENA) in terms of the number of adults with diabetes (5.4 million), estimated that about 9.2 million Iranians may catch the disease by 2030. Type 2 diabetes is a complex metabolic illness caused by genetic and non-genetic (environmental) factors. The heritability of T2D varies between 20% and 80%, indicating that genetic factors play a significant part in the disease's development; the disease's heritable component is polygenic, meaning that multiple genes and their variations contribute to an increased risk of T2D development. The introduction of high-throughput genotyping technologies has greatly advanced our understanding of the genetic components of complex disorders, such as T2D.
Additionally, by comparing polymorphisms in two distinct populations (one healthy and one diseased), genome-wide association studies (GWAS) can uncover links between SNPs and common illness risk. GWAS can begin to untangle the molecular mechanisms underlying disease states by finding probable causative variables risk stratification. Single-celled organisms, such as bacteria, even have SNPs. SNP genotyping can discriminate between microorganism isolates and might even be accustomed to characterizing antibiotic resistance strains. SNP-based strain detection has relevance in each clinical and pharmaceutical analysis and has been used to study the spread of infectious diseases in humans. Over the last decade, next-generation sequencing (NGS) technology has enabled simultaneous testing of multiple disease genes, from targeted gene panels to exome sequencing (ES) and genomic sequencing (GS). GS is quickly becoming a practical first-stage test as costs decrease and performance improves. More and more studies show that GS can detect an unprecedented range of pathogenic abnormalities in a single laboratory. GS has the potential to provide patients with unbiased, rapid, and accurate molecular diagnostics that transcend diverse clinical indications and complex conditions. Therefore, the use in drug development for genetic and rare diseases will be one of the key factors driving the growth of the genotyping markets during the forecast period.
Middle East & Africa Genotyping Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Genotyping Market Segmentation
The Middle East & Africa genotyping market is segmented by products and services, technology, application, end user, and country. Based on products and services, the market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment is dominating the market in 2022.
Based on technology, the market is segmented into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF) mass spectrometry, polymerase chain reaction (PCR), and others. The PCR segment is dominating the market in 2022.
Based on application, the market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. The diagnostics and personalized medicine segment is dominating the market in 2022.
Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. The diagnostics and research laboratories segment is dominating the market in 2022.
Based on country, the market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. Further, the Rest of the Middle East & Africa is dominating the market in 2022.
A few key players dominating the Middle East & Africa genotyping market are BioTek Instruments, Inc.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Integrated DNA Technologies, Inc.; MERCK KGaA; QIAGEN; Thermo Fisher Scientific Inc; and TrimGen Corporation.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Genotyping Market - By Product and Services
1.3.2 MEA Genotyping Market - By Technology
1.3.3 MEA Genotyping Market - By Application
1.3.4 MEA Genotyping Market - By End User
1.3.5 MEA Genotyping Market - By Country
2. MEA Genotyping Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Genotyping Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Genotyping Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Use of Genotyping in Drug Development for Genetic and Rare Diseases
5.1.2 Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of skilled Professionals required for Genotyping process
5.3 Market Opportunities
5.3.1 Wide Applications of Genotyping
5.4 Future Trends
5.4.1 Rising focus on Personalized Medicine
5.5 Impact analysis
6. Genotyping Market- MEA Analysis
6.1 MEA Genotyping Market Revenue Forecast and Analysis
7. MEA Genotyping Market- by Product and Services
7.1 Overview
7.2 MEA Genotyping Market, By Product and Services, 2022 & 2028 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Bioinformatics
7.5.1 Overview
7.5.2 Bioinformatics: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Instruments
7.6.1 Overview
7.6.2 Instruments: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
8. MEA Genotyping Market- by Technology
8.1 Overview
8.2 MEA Genotyping Market Share by Technology - 2022 & 2028 (%)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.4 Capillary Electrophoresis (CE)
8.4.1 Overview
8.4.2 Capillary Electrophoresis: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.5 Sequencing
8.5.1 Overview
8.5.2 Sequencing: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.6 Microarrays
8.6.1 Overview
8.6.2 Microarrays: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.7 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry
8.7.1 Overview
8.7.2 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Genotyping Market-by Application
9.1 Overview
9.2 MEA Genotyping Market Share by Application - 2022 & 2028 (%)
9.3 Diagnostics and Personalized Medicine
9.3.1 Overview
9.3.2 Diagnostics and Personalized Medicine: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.4 Pharmacogenomics
9.4.1 Overview
9.4.2 Pharmacogenomics: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.5 Animal Genetics
9.5.1 Overview
9.5.2 Animal Genetics: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.6 Agricultural Biotechnology
9.6.1 Overview
9.6.2 Agricultural Biotechnology: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Genotyping Market- by End User
10.1 Overview
10.2 MEA Genotyping Market Share by End User- 2022 & 2028 (%)
10.3 Diagnostic and Research Laboratories
10.3.1 Overview
10.3.2 Diagnostic and Research Laboratories: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.4 Pharmaceutical and Biopharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biopharmaceutical Companies: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.5 Academic Institutes
10.5.1 Overview
10.5.2 Academic Institutes: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
11. MEA Genotyping Market- Country Analysis
11.1 MEA Genotyping Market Revenue and Forecasts to 2028
11.1.1 Overview
11.1.3 MEA Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.1.3.1 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.1.1 Overview
11.1.3.1.2 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.1.3 UAE: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.1.4 UAE: Genotyping Market, by Technology, 2019-2028 (US$ Million)
11.1.3.1.5 UAE: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.1.6 UAE: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.1.3.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.2.1 Overview
11.1.3.2.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.2.3 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.2.4 Saudi Arabia: Genotyping Market, by Technology, 2019-2028 (US$ Million)
11.1.3.2.5 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.2.6 Saudi Arabia: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.1.3.3 South Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.3.1 Overview
11.1.3.3.2 South Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.3.3 South Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.3.4 South Africa: Genotyping Market, by Technology, 2019-2028 (US$ Million)
11.1.3.3.5 South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.3.6 South Africa: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.1.3.4 Rest of MEA: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.4.1 Overview
11.1.3.4.2 Rest of MEA: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.4.3 Rest of MEA: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.4.4 Rest of MEA: Genotyping Market, by Technology, 2019-2028 (US$ Million)
11.1.3.4.5 Rest of MEA: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.4.6 Rest of MEA: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12. MEA Genotyping Market Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MERCK KGaA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioTek Instruments, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 TRIMGEN CORPORATION
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 SWOT Analysis
13.7.5 Key Developments
13.8 Illumina, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Genotyping Market -Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 3. UAE: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 5. UAE: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 7. Saudi Arabia: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 8. Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 9. Saudi Arabia: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 11. South Africa: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 12. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 13. South Africa: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of MEA: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 15. Rest of MEA: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of MEA: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 17. Rest of MEA: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 18. Organic Developments Done By Companies
Table 19. Inorganic Developments Done By Companies
Table 20. Glossary of Terms
LIST OF FIGURES
Figure 1. MEA Genotyping Market Segmentation
Figure 2. MEA Genotyping Market - By Country
Figure 3. MEA Genotyping Market Overview
Figure 4. Reagents and Kits Held Largest Share by Product and Services of MEA Genotyping Market
Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period
Figure 6. MEA: PEST Analysis
Figure 7. Experts Opinion
Figure 8. MEA Genotyping Market Impact Analysis of Driver and Restraints
Figure 9. MEA Genotyping Market- Revenue Forecast and Analysis - 2022 - 2028
Figure 10. MEA Genotyping Market, by Product and Services, 2022 & 2028 (%)
Figure 11. Reagents and Kits: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Genotyping Services: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Bioinformatics: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Instruments: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. MEA Genotyping Market Share by Technology - 2022 & 2028 (%)
Figure 16. Polymerase Chain Reaction: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Capillary Electrophoresis: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Sequencing: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Microarrays: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Others: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. MEA Genotyping Market Share by Application - 2022 & 2028 (%)
Figure 23. Diagnostics and Personalized Medicine: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Pharmacogenomics: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Animal Genetics: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Agricultural Biotechnology: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Others: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. MEA Genotyping Market Share by End User- 2022 & 2028 (%)
Figure 29. Diagnostic and Research Laboratories: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Pharmaceutical and Biopharmaceutical Companies: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Academic Institutes: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Others: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. MEA Genotyping Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 34. MEA Genotyping Market Revenue and Forecasts to 2028, By Country (%)
Figure 35. UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. South Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Rest of MEA: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security